i4i Connect: funding for SMEs to accelerate medical technology development

Key Features

The National Institute for Health Research (NIHR) Invention for Innovation (i4i) Programme is launching a new funding stream – i4i Connect – aimed at small and medium-sized enterprises (SMEs) in need of a funding boost to reach their next stage in the development pathway.

Programme:     NIHR i4i Programme

Award:     Up to £150k

Opens: 16th Aug 2017

Closes: 13th Sep 2017

! This scheme is now closed

The NIHR Invention for Innovation (i4i) Programme has launched a new funding stream – i4i Connect – aimed at small and medium-sized enterprises (SMEs) in need of a funding boost to reach their next stage in the development pathway.

Offering up to £150,000 over a 6-12 month period, i4i Connect will help SMEs get to the point of eligibility for a full i4i award or, down the line, follow on-funding. This will enable accelerated development of promising medical technologies, in line with recommendations from the Government’s Accelerated Access Review.

NIHR’s i4i Programme is a translational funding scheme that supports healthcare technologies, devices and interventions for patient benefit in areas of existing or emerging clinical need. The aim is to de-risk projects, making them attractive to follow-on funders and investors. i4i Connect is specifically tailored for SMEs at this later point of product development, as well as in the early stage to provide support on the pathway to full i4i funding, with an NHS or academic partner.

The awards are based on a two stage application process:

Scope

  • R&D towards medical devices, active implantable devices and in vitro diagnostic devices as defined by relevant EU directives
  • R&D towards technologies or interventions specified by Challenge Award themes
  • Product development to enable a technology for clinical use including around manufacturing, IP protection, freedom to operate and market analysis, business case development
  • Feasibility studies or R&D of techniques or technologies from a different industry sector with potential impact if applied in a healthcare setting
  • Studies to provide data relating to safety and effectiveness of a device including first-in-man and pivotal studies
  • Health economic analyses and clinical utility studies looking at a device’s real-life implementation and use
  • CE marking and other regulatory requirements including any associated safety trials
  • Activities associated with the adoption of new technology
  • Training associated with the implementation of new technology